Jan-Hermen Dannenberg

Director Target Discovery at Genmab

Utrecht, Utrecht, Netherlands

About

Experience

  • Genmab (13 yrs 3 mos)
    • Director Target Discovery
      Jan 2021 - Present · 5 yrs 7 mos

    • Associate Director Target Discovery
      Jul 2018 - Jan 2021 · 2 yrs 7 mos

    • Prinicipal Scientist
      Jan 2017 - Jul 2018 · 1 yr 7 mos

  • Junior group leader at Netherlands Cancer Institute
    Mar 2007 - Apr 2013 · 6 yrs 2 mos

    Co-promoter M.R. Heideman. Thesis: "Gene control and remodeling during hematopoiesis". Co-promoter R.H. Wilting: Thesis: "Inactivate the two-faced HDAC-brake: Cell cycle regulation and tumorsuppression by histone deacetylases HDAC1 and HDAC2" Research funded by grants from -Dutch Cancer Society -Netherlands Scientific Organization (NWO) - VIDI

  • Dana-Farber Cancer Institute/Harvard Medical School (Boston, MA, USA)
    • Dutch Cancer Society post-doctoral fellow
      Jun 2003 - Jul 2006 · 3 yrs 2 mos

    • Damon Runyon Cancer Research post-doctoral fellow
      Jun 2002 - Jun 2003 · 1 yr 1 mo